Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline and Zinc in Idiopathic Male Infertility
NCT05178953Phase 1Unknown
- Sponsor
- Arak University of Medical Sciences
- Start
- Aug 2021
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in male infertility comparing Pentoxifylline Group, Zinc Sulfate Group and Pentoxifylline + Zinc Group (3 arms). Primary endpoints: sperm concentration at 3 months, sperm motility at 3 months and 10 more. Status: unknown.
02
Drugs
pentoxifyllinezinc
03
Conditions
male infertility
Beyond the preview
Go deeper on NCT05178953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05178953.